Nordic Secondary Fund is pleased to announce that we have acquired a stake in CathVision, a developer of innovative products for cardiac ablation therapy.
CathVision aim to cure cardiac arrhythmia by empowering healthcare professionals with cutting-edge technology. CathVision develops a low-noise electrophysiology (EP) recording system, CathVision Cube, to help better guide ablation therapy through exceptional EP signal quality. The product comprises a proprietary low-noise console and computer software to stream, analyze and store EP signals.
With the investment in CathVision Nordic Secondary Fund I’s portfolio now consists of: Klarna, OnRobot, ROOM, Click & Grow, MapsPeople, GoMore, Varjo, Norlase and CathVision.
Learn more about CathVision on their website: CathVision.com
